Drug Profile
TRC 30X
Latest Information Update: 22 Nov 2019
Price :
$50
*
At a glance
- Originator Torrent Pharmaceuticals
- Class Class II antiarrhythmics; Class III antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 22 Nov 2019 Discontinued - Phase-I for Arrhythmias in India (unspecified route)
- 04 Sep 2002 Phase-I clinical trials in Arrhythmias in India (unspecified route)